147 related articles for article (PubMed ID: 23159930)
1. Class IIa HDACs repressive activities on MEF2-depedent transcription are associated with poor prognosis of ER⁺ breast tumors.
Clocchiatti A; Di Giorgio E; Ingrao S; Meyer-Almes FJ; Tripodo C; Brancolini C
FASEB J; 2013 Mar; 27(3):942-54. PubMed ID: 23159930
[TBL] [Abstract][Full Text] [Related]
2. The co-existence of transcriptional activator and transcriptional repressor MEF2 complexes influences tumor aggressiveness.
Di Giorgio E; Franforte E; Cefalù S; Rossi S; Dei Tos AP; Brenca M; Polano M; Maestro R; Paluvai H; Picco R; Brancolini C
PLoS Genet; 2017 Apr; 13(4):e1006752. PubMed ID: 28419090
[TBL] [Abstract][Full Text] [Related]
3. All trans-retinoic acid modulates the procoagulant activity of human breast cancer cells.
Marchetti M; Russo L; Balducci D; Falanga A
Thromb Res; 2011 Oct; 128(4):368-74. PubMed ID: 21458031
[TBL] [Abstract][Full Text] [Related]
4. Beside the MEF2 axis: unconventional functions of HDAC4.
Clocchiatti A; Di Giorgio E; Demarchi F; Brancolini C
Cell Signal; 2013 Jan; 25(1):269-76. PubMed ID: 23063464
[TBL] [Abstract][Full Text] [Related]
5. High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors.
Marot D; Bieche I; Aumas C; Esselin S; Bouquet C; Vacher S; Lazennec G; Perricaudet M; Kuttenn F; Lidereau R; de Roux N
Endocr Relat Cancer; 2007 Sep; 14(3):691-702. PubMed ID: 17914099
[TBL] [Abstract][Full Text] [Related]
6. pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer.
Macaluso M; Cinti C; Russo G; Russo A; Giordano A
Oncogene; 2003 Jun; 22(23):3511-7. PubMed ID: 12789259
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional induction of MMP-10 by TGF-beta, mediated by activation of MEF2A and downregulation of class IIa HDACs.
Ishikawa F; Miyoshi H; Nose K; Shibanuma M
Oncogene; 2010 Feb; 29(6):909-19. PubMed ID: 19935709
[TBL] [Abstract][Full Text] [Related]
8. Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer.
Rennstam K; McMichael N; Berglund P; Honeth G; Hegardt C; Rydén L; Luts L; Bendahl PO; Hedenfalk I
Breast Cancer Res Treat; 2010 Jul; 122(2):315-24. PubMed ID: 19795205
[TBL] [Abstract][Full Text] [Related]
9. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
[TBL] [Abstract][Full Text] [Related]
10. Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue.
Hein S; Müller V; Köhler N; Wikman H; Krenkel S; Streichert T; Schweizer M; Riethdorf S; Assmann V; Ihnen M; Beck K; Issa R; Jänicke F; Pantel K; Milde-Langosch K
Breast Cancer Res Treat; 2011 Sep; 129(2):347-60. PubMed ID: 20972617
[TBL] [Abstract][Full Text] [Related]
11. Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer.
Tabuchi Y; Matsuoka J; Gunduz M; Imada T; Ono R; Ito M; Motoki T; Yamatsuji T; Shirakawa Y; Takaoka M; Haisa M; Tanaka N; Kurebayashi J; Jordan VC; Naomoto Y
Int J Oncol; 2009 Feb; 34(2):313-9. PubMed ID: 19148464
[TBL] [Abstract][Full Text] [Related]
12. HDAC6 expression is correlated with better survival in breast cancer.
Zhang Z; Yamashita H; Toyama T; Sugiura H; Omoto Y; Ando Y; Mita K; Hamaguchi M; Hayashi S; Iwase H
Clin Cancer Res; 2004 Oct; 10(20):6962-8. PubMed ID: 15501975
[TBL] [Abstract][Full Text] [Related]
13. Converse role of class I and class IIa HDACs in the progression of atrial fibrillation.
Zhang D; Hu X; Li J; Hoogstra-Berends F; Zhuang Q; Esteban MA; de Groot N; Henning RH; Brundel BJJM
J Mol Cell Cardiol; 2018 Dec; 125():39-49. PubMed ID: 30321539
[TBL] [Abstract][Full Text] [Related]
14. IL-8 expression and its possible relationship with estrogen-receptor-negative status of breast cancer cells.
Freund A; Chauveau C; Brouillet JP; Lucas A; Lacroix M; Licznar A; Vignon F; Lazennec G
Oncogene; 2003 Jan; 22(2):256-65. PubMed ID: 12527894
[TBL] [Abstract][Full Text] [Related]
15. The emerging role of class II histone deacetylases.
Fischle W; Kiermer V; Dequiedt F; Verdin E
Biochem Cell Biol; 2001; 79(3):337-48. PubMed ID: 11467747
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the function of class IIa HDACs by blocking their interaction with MEF2.
Jayathilaka N; Han A; Gaffney KJ; Dey R; Jarusiewicz JA; Noridomi K; Philips MA; Lei X; He J; Ye J; Gao T; Petasis NA; Chen L
Nucleic Acids Res; 2012 Jul; 40(12):5378-88. PubMed ID: 22396528
[TBL] [Abstract][Full Text] [Related]
17. Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases.
Lu J; McKinsey TA; Nicol RL; Olson EN
Proc Natl Acad Sci U S A; 2000 Apr; 97(8):4070-5. PubMed ID: 10737771
[TBL] [Abstract][Full Text] [Related]
18. PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer.
Ghosh MG; Thompson DA; Weigel RJ
Cancer Res; 2000 Nov; 60(22):6367-75. PubMed ID: 11103799
[TBL] [Abstract][Full Text] [Related]
19. Class IIa histone deacetylases and myocyte enhancer factor 2 proteins regulate the mesenchymal-to-epithelial transition of somatic cell reprogramming.
Zhuang Q; Qing X; Ying Y; Wu H; Benda C; Lin J; Huang Z; Liu L; Xu Y; Bao X; Qin B; Pei D; Esteban MA
J Biol Chem; 2013 Apr; 288(17):12022-31. PubMed ID: 23467414
[TBL] [Abstract][Full Text] [Related]
20. Targeting Id1 and Id3 by a specific peptide aptamer induces E-box promoter activity, cell cycle arrest, and apoptosis in breast cancer cells.
Mern DS; Hoppe-Seyler K; Hoppe-Seyler F; Hasskarl J; Burwinkel B
Breast Cancer Res Treat; 2010 Dec; 124(3):623-33. PubMed ID: 20191379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
